investorscraft@gmail.com

Intrinsic ValueHunan Haili Chemical Industry Co., Ltd. (600731.SS)

Previous Close$7.57
Intrinsic Value
Upside potential
Previous Close
$7.57

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Hunan Haili Chemical Industry Co., Ltd. operates as a specialized manufacturer and trader within China's agricultural inputs sector, focusing on the development and production of pesticides and fine chemicals. Its core revenue model is built on the sale of a diversified portfolio of crop protection products, including insecticides, fungicides, and phosgenation products, alongside pesticide intermediates and seed coating agents marketed under its established Haili brand. The company is deeply integrated into the domestic agricultural supply chain, serving the critical need for yield enhancement and crop health management. Its market position is that of a niche player in the basic materials sector, leveraging its chemical expertise to cater to the specific demands of Chinese farmers and agro-industrial clients. This focus on a specialized product range within a vast market provides a defensible, albeit competitive, operational footprint.

Revenue Profitability And Efficiency

The company generated revenue of CNY 2.47 billion, achieving a net income of CNY 265.4 million, which indicates a healthy net profit margin of approximately 10.7%. This demonstrates an ability to convert a significant portion of its sales into bottom-line earnings. Operating cash flow was strong at CNY 371.1 million, comfortably covering capital expenditures and supporting overall financial flexibility.

Earnings Power And Capital Efficiency

Diluted earnings per share stood at CNY 0.48, reflecting the firm's earnings power on a per-share basis. The positive operating cash flow significantly exceeded net income, indicating high-quality earnings that are not solely reliant on accounting accruals. Capital expenditures of CNY 216.8 million represent a reinvestment into maintaining and potentially expanding its production capabilities.

Balance Sheet And Financial Health

Financial health appears robust, with a substantial cash and equivalents position of CNY 1.08 billion against total debt of CNY 431.8 million. This results in a net cash position, providing a strong liquidity buffer and low financial risk. The conservative capital structure is further evidenced by a low beta of 0.351, suggesting lower volatility compared to the broader market.

Growth Trends And Dividend Policy

The company has demonstrated a shareholder-friendly capital allocation policy by paying a dividend of CNY 0.20 per share. This commitment to returning capital, combined with its solid cash generation, points to a stable financial policy. Future growth will likely be driven by its ongoing operations within the agricultural chemical sector and its capacity investments.

Valuation And Market Expectations

With a market capitalization of approximately CNY 4.03 billion, the market values the company at a price-to-earnings multiple derived from its current earnings and share count. The low beta suggests investor perception of it as a relatively stable, lower-risk investment within its sector, potentially reflecting expectations of steady, rather than explosive, growth.

Strategic Advantages And Outlook

The company's strategic advantages lie in its specialized focus on agricultural chemicals and its established Haili brand within China. Its strong balance sheet provides a significant advantage for weathering industry cycles or pursuing selective opportunities. The outlook is tied to the performance of the domestic agricultural sector and the company's execution in a competitive market.

Sources

Company description and financial data provided in user request

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount